The Herceptin biosimilar market is expected to show consistent growth as regulatory confidence, reimbursement support, and oncology demand converge. The Herceptin Biosimilar Market forecast suggests that biosimilars will continue capturing larger shares of the oncology biologics segment through 2035. Factors such as increasing cancer prevalence, cost-containment policies, and expiry of patent...